This session offers an in-depth exploration of precision plaque management strategies through hybrid lesion preparation techniques and advanced intravascular ultrasound (IVUS) imaging. It emphasizes the synergistic use of drug-coated balloons and drug-eluting stents to optimize PCI outcomes. Participants will gain a deeper understanding of how cutting...

This session highlights the emerging role of next-generation resorbable magnesium scaffolds in coronary interventions. It provides detailed insights into the FREESOLVE technology, its clinical applications, and the latest evidence from the BIOMAG-I study with three-year outcomes. Clinical experiences with FREESOLVE are discussed to inform on safety,...

This session addresses the critical nursing roles in managing patients requiring mechanical circulatory support (MCS). It covers essential concepts in hemodynamic interpretation, large bore vascular access complications, and their nursing management in critical care settings. The session includes practical guidance on vascular closure devices, wound care,...

A study to determine the long-term outcomes of high-risk patients who underwent transcatheter aortic valve implantation with the third-generation CoreValve device, according to the 2017 EAPCI/ESC/EACTS definition of valve durability.

Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.

The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications. 

Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

In collaboration with EuroIntervention Journal

The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...

Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)